Oncology medication prices can vary significantly between countries – but by how much and why?

How do we move on from a sombre start to 2016?

Many drug candidates are as poorly soluble as “brick dust”, making oral delivery a significant challenge.

2015 has been a difficult year for Indian pharma companies – and ASSOCHAM is calling for the country to get its “house in order”.

A new personalized test aims to predict which side effects a patient will suffer from.

The AMA calls for a ban on direct-to-consumer drug advertising in the US. But is such prohibition realistic?

The UK aims high with a new manufacturing center designed to meet the needs of cell and gene therapies.

Pfizer and Allergan are to combine to form the world’s biggest pharma behemoth – for tax?

From Iceland’s volcanic springs to a lab in South Denmark; does the microbe Sulfolobus. islandicus hold the key to a drug’s safe transit through the gut?

A capsule being developed in Ireland aims to contain not medicine, but process analytical technology.